CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Shenzhen Kangtai Biological Products Co Ltd Company Snapshot
Shenzhen Kangtai Biological Products Co Ltd operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Kangtai Biological Products Co Ltd with three other companies in this sector in China: Shanghai Raas Blood Products Company Limited (2018 sales of 1.80 billion Chinese Renmimbi [US$258.08 million] of which 40% was Albumin), Jinyu Bio-Technology Co Ltd (1.90 billion Chinese Renmimbi [US$271.29 million] of which 97% was Bio-Pharmaecutical), and Beijing SL Pharmaceutical Co Ltd (2.17 billion Chinese Renmimbi [US$310.04 million] of which 99% was Pharmaceuticals Industry).

Sales Analysis. During the year ended December of 2018, sales at Shenzhen Kangtai Biological Products Co Ltd were 2.02 billion Chinese Renmimbi (US$288.35 million). This is an increase of 73.6% versus 2017, when the company's sales were 1.16 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shenzhen Kangtai Biological Products Co Ltd (and since 2013, sales have increased a total of 706%). Sales of Biological Products saw an increase of 73.8% in 2018, from 1.16 billion Chinese Renmimbi to 2.01 billion Chinese Renmimbi.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Shenzhen Kangtai Biological Products Co Ltd
  Stock Performance Chart for Shenzhen Kangtai Biological Products Co Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 85.03
(Figures in Chinese Renmimbi)
1 Week -1.7%   13 Weeks 1.3%  
4 Weeks 29.0%   52 Weeks 131.1%  
 
Shenzhen Kangtai Biological Products Co Ltd Key Data:
  Ticker: 300601 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 2,015,852,581
(Year Ending Jan 2019).
Employees: 1,146
  Currency: Chinese Renmimbi Market Cap: 53,999,909,417
  Fiscal Yr Ends: December Shares Outstanding: 635,068,910
  Share Type: A Gu Closely Held Shares:
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.